Santhera Pharmaceuticals Holding AG Cash Flow Reinvestment Rate
Santhera Pharmaceuticals Holding AG cash flow reinvestment rate. Santhera Pharmaceuticals Holding AG (SANN) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting CHF90.00K (capex CHF90.00K ) from operating cash flow of CHF62.63 Million. Explore how well can Santhera Pharmaceuticals Holding AG service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Santhera Pharmaceuticals Holding AG (2019–2023)
Cash flow reinvestment rate of Santhera Pharmaceuticals Holding AG from 2019 to 2023. Historical reinvestment intensity for Santhera Pharmaceuticals Holding AG across 2 annual periods. Explore Santhera Pharmaceuticals Holding AG (SANN) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Santhera Pharmaceuticals Holding AG Cash Flow Reinvestment Rate by Year (2019–2023)
Santhera Pharmaceuticals Holding AG cash flow reinvestment rate by year from 2019 to 2023. Year-by-year capital reinvestment analysis for Santhera Pharmaceuticals Holding AG. For the full cash flow conversion analysis, see Santhera Pharmaceuticals Holding AG cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.88x | CHF41.79 Million | CHF47.27 Million | CHF23.74 Million | ▲ +828.7% |
| 2019 | 0.10x | CHF247.00K | CHF2.60 Million | CHF229.00K | — |